144 related articles for article (PubMed ID: 20116344)
1. Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging.
Sloboda RS; Usmani N; Pedersen J; Murtha A; Pervez N; Yee D
Brachytherapy; 2010; 9(4):354-61. PubMed ID: 20116344
[TBL] [Abstract][Full Text] [Related]
2. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
[TBL] [Abstract][Full Text] [Related]
3. Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique.
Chung E; Stenmark MH; Evans C; Narayana V; McLaughlin PW
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1944-8. PubMed ID: 21640498
[TBL] [Abstract][Full Text] [Related]
4. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
Crook J; McLean M; Yeung I; Williams T; Lockwood G
Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
[TBL] [Abstract][Full Text] [Related]
5. Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion.
Tanaka O; Hayashi S; Matsuo M; Nakano M; Uno H; Ohtakara K; Miyoshi T; Deguchi T; Hoshi H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):614-8. PubMed ID: 17869675
[TBL] [Abstract][Full Text] [Related]
6. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
[TBL] [Abstract][Full Text] [Related]
7. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
Albertsen PC
J Urol; 2005 Nov; 174(5):1969-70. PubMed ID: 16217368
[No Abstract] [Full Text] [Related]
8. Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate.
Roeloffzen EM; Monninkhof EM; Battermann JJ; van Roermund JG; Moerland MA; van Vulpen M
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):76-84. PubMed ID: 20605364
[TBL] [Abstract][Full Text] [Related]
9. [Changes of edema associated with I-125 prostate brachytherapy].
Aoki M; Miki K; Takahashi H; Takagi S; Fukuda I; Honda C; Kobayashi M; Egawa S; Kanehira C
Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Oct; 65(4):411-8. PubMed ID: 16334395
[TBL] [Abstract][Full Text] [Related]
10. Effect of post-implant edema on prostate brachytherapy treatment margins.
Reed DR; Wallner K; Ford E; Mueller A; Merrick G; Maki J; Sutlief S; Butler W
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1469-73. PubMed ID: 16137839
[TBL] [Abstract][Full Text] [Related]
11. Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation.
Smith RP; Beriwal S; Komanduri K; Gibbons E; Benoit R
Brachytherapy; 2008; 7(3):237-41. PubMed ID: 18599357
[TBL] [Abstract][Full Text] [Related]
12. External beam radiotherapy boosts to reduce the impact caused by edema in prostate permanent seed implants.
Yue N; Mori J; Nath R; Heron DE; Huq MS
Phys Med Biol; 2006 May; 51(9):2267-77. PubMed ID: 16625041
[TBL] [Abstract][Full Text] [Related]
13. Epididymitis after prostate brachytherapy.
Hoffelt SC; Wallner K; Merrick G
Urology; 2004 Feb; 63(2):293-6. PubMed ID: 14972474
[TBL] [Abstract][Full Text] [Related]
14. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
International Commission on Radiological Protection
Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
[TBL] [Abstract][Full Text] [Related]
15. Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer.
Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook JM
Brachytherapy; 2008; 7(2):200-5. PubMed ID: 18362087
[TBL] [Abstract][Full Text] [Related]
16. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer.
Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J
Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446
[TBL] [Abstract][Full Text] [Related]
17. Minimizing the number of implantation needles for prostate (125)I brachytherapy: an investigation of possibilities and implications.
Steggerda MJ; van der Poel HG; Moonen LM
Brachytherapy; 2010; 9(4):319-27. PubMed ID: 20691644
[TBL] [Abstract][Full Text] [Related]
18. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
[TBL] [Abstract][Full Text] [Related]
19. Impact of intraoperative edema during transperineal permanent prostate brachytherapy on computer-optimized and preimplant planning techniques.
Yamada Y; Potters L; Zaider M; Cohen G; Venkatraman E; Zelefsky MJ
Am J Clin Oncol; 2003 Oct; 26(5):e130-5. PubMed ID: 14528087
[TBL] [Abstract][Full Text] [Related]
20. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.
Waterman FM; Yue N; Corn BW; Dicker AP
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1069-77. PubMed ID: 9719117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
